Bullous pemphigoid induced by <scp>IgG</scp> targeting type <scp>XVII</scp> collagen <scp>non‐NC16A</scp> / <scp>NC15A</scp> extracellular domains is driven by Fc gamma receptor‐ and complement‐mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade
Manuela Pigors(University of Lübeck), Enno Schmidt(Carrier (United States)), Ralf J. Ludwig(University of Lübeck), Maxi Hofrichter(University of Lübeck), Shirin Emtenani(University of Lübeck), Bianca Balbino(Argenx (Belgium)), Mayumi Kamaguchi(University of Lübeck), Stanislav Khil’chenko(University of Lübeck), Lars Komorowski(Euroimmun Medizinische Labordiagnostika (Germany)), Jenny Dworschak(Euroimmun Medizinische Labordiagnostika (Germany)), Katja Bieber(University of Lübeck), Stephanie Goletz(University of Lübeck), Sabrina Patzelt(University of Lübeck), Gabriele Köhl(University of Lübeck), Christian Probst(Mayo Clinic), Katrien Vanderheyden(Argenx (Belgium)), Peter Verheesen(Argenx (Belgium)), Jörg Köhl(University of Lübeck), Niklas Reichhelm(University of Lübeck)
Cited by 21
Related Papers
Psoriasis: a possible risk factor for development of coronary artery calcification
|British Journal of Dermatology|2006|376
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|373
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|370
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332